The discovery of 3039-0164 opens up new avenues for research and design optimization of PRMT5 inhibitors, which can help improve the prognosis of non-small cell lung cancer and other cancers in the clinic. The gene discussed is PRMT5; the disease is non-small cell lung carcinoma.